Emanuele Cassarà

1.0k total citations
21 papers, 661 citations indexed

About

Emanuele Cassarà is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Emanuele Cassarà has authored 21 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 7 papers in Immunology and 5 papers in Hematology. Recurrent topics in Emanuele Cassarà's work include Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (11 papers) and Systemic Lupus Erythematosus Research (6 papers). Emanuele Cassarà is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (11 papers) and Systemic Lupus Erythematosus Research (6 papers). Emanuele Cassarà collaborates with scholars based in Italy, United States and Poland. Emanuele Cassarà's co-authors include Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, O. Kaloudi, Carlo Salvarani, Ivo Lenzetti, Guido Valesini, Maurizio Benucci, Ignazio Olivieri and Michele Bertoni and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Seminars in Arthritis and Rheumatism.

In The Last Decade

Emanuele Cassarà

20 papers receiving 637 citations

Peers

Emanuele Cassarà
Emanuele Cassarà
Citations per year, relative to Emanuele Cassarà Emanuele Cassarà (= 1×) peers Gülay Kınıklı

Countries citing papers authored by Emanuele Cassarà

Since Specialization
Citations

This map shows the geographic impact of Emanuele Cassarà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuele Cassarà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuele Cassarà more than expected).

Fields of papers citing papers by Emanuele Cassarà

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuele Cassarà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuele Cassarà. The network helps show where Emanuele Cassarà may publish in the future.

Co-authorship network of co-authors of Emanuele Cassarà

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuele Cassarà. A scholar is included among the top collaborators of Emanuele Cassarà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuele Cassarà. Emanuele Cassarà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benucci, Maurizio, et al.. (2025). Single-Center Cross-Sectional Analysis of Patients with RA, SpA, and PsA: Data from the Prescription Database. Journal of Personalized Medicine. 15(8). 366–366.
2.
Cassarà, Emanuele, et al.. (2024). Analysis and Optimization of a Regenerative Snubber for a GaN-Based USB-PD Flyback Converter. Electronics. 13(6). 1045–1045. 1 indexed citations
3.
Niccoli, Laura, Carlotta Nannini, Corrado Blandizzi, et al.. (2018). Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables. Therapeutics and Clinical Risk Management. Volume 14. 2097–2111. 4 indexed citations
4.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, & O. Kaloudi. (2017). Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator. European Journal of Rheumatology. 4(4). 288–290. 15 indexed citations
5.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, et al.. (2017). Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis. The Journal of Rheumatology. 44(9). 1341–1346. 16 indexed citations
6.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, et al.. (2017). Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Seminars in Arthritis and Rheumatism. 47(2). 183–192. 63 indexed citations
7.
Niccoli, Laura, Emanuele Cassarà, O. Kaloudi, et al.. (2015). Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report. BMC Musculoskeletal Disorders. 16(1). 146–146. 1 indexed citations
8.
Cantini, Fabrizio, Carlotta Nannini, Emanuele Cassarà, O. Kaloudi, & Laura Niccoli. (2015). Uveitis in Spondyloarthritis: An Overview. PubMed. 93(0). 27–29. 40 indexed citations
9.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, O. Kaloudi, & Emanuele Cassarà. (2012). Infliximab in Psoriatic Arthritis. PubMed. 89(0). 71–73. 10 indexed citations
10.
Niccoli, Laura, Carlotta Nannini, Emanuele Cassarà, et al.. (2012). Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. International Journal of Rheumatic Diseases. 15(4). 414–418. 50 indexed citations
11.
Niccoli, Laura, Carlotta Nannini, Emanuele Cassarà, O. Kaloudi, & Fabrizio Cantini. (2011). Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti‐TNFα drugs and therapy‐induced changes. International Journal of Rheumatic Diseases. 15(1). 56–61. 17 indexed citations
12.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, et al.. (2010). Psoriatic arthritis: a systematic review. International Journal of Rheumatic Diseases. 13(4). 300–317. 75 indexed citations
13.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, et al.. (2009). Criteria, Frequency, and Duration of Clinical Remission in Psoriatic Arthritis Patients with Peripheral Involvement Requiring Second-line Drugs. PubMed. 83(0). 78–80. 14 indexed citations
15.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, et al.. (2008). Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. Lara D. Veeken. 47(6). 872–876. 64 indexed citations
16.
Iagnocco, Annamaria, Emilio Filippucci, Chiara Perella, et al.. (2008). Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis.. PubMed. 35(1). 35–40. 74 indexed citations
17.
Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, et al.. (2007). Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described. Annals of the Rheumatic Diseases. 66(12). 1672–1674. 4 indexed citations
18.
Niccoli, Laura, Carlotta Nannini, Maurizio Benucci, et al.. (2007). Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study. Lara D. Veeken. 46(7). 1161–1164. 119 indexed citations
19.
Priori, Roberta, Emanuela Medda, Fabrizio Conti, et al.. (2007). Risk factors for Sjögren's syndrome: a case-control study.. PubMed. 25(3). 378–84. 36 indexed citations
20.
Cassarà, Emanuele, et al.. (2003). Thalidomide: focus on its employment in rheumatologic diseases.. PubMed. 20(5). 709–18. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026